St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Surveillance of Influenza Virus Among Children With Febrile Respiratory Complaints Attending the Pediatric Clinic of the First Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, Mainland China
Completed
- Conditions
- Influenza Type AInfluenza Type B
- Interventions
- Other: Nasopharyngeal Swab
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 13201
- Registration Number
- NCT00760500
- Locations
- 🇨🇳
First Affiliated Hospital, Shantou, Guangdong, China
Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages
Completed
- Conditions
- Immunodeficiency
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 14
- Registration Number
- NCT00758992
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors
Phase 1
Completed
- Conditions
- Recurrent or Refractory Solid TumorsCNS Malignancies
- Interventions
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT00756340
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
Phase 1
Completed
- Conditions
- MelanomaEwing SarcomaOsteosarcomaNeuroblastoma
- Interventions
- Biological: Anti-GD2 antibody
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00743496
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Pharmacogenetic Determinants Of Treatment Response In Children
Recruiting
- Conditions
- All MalignanciesChildren Being Treated for Catastrophic Illness
- First Posted Date
- 2008-08-08
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 8800
- Registration Number
- NCT00730678
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
Phase 1
Completed
- Conditions
- Non-Hodgkins LymphomaHodgkin's DiseaseAcute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2013-08-28
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT00718757
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸Rady's Children Hospital San Diego, San Diego, California, United States
AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone
Completed
- Conditions
- Avascular NecrosisAcute Lymphoblastic Leukemia
- Interventions
- Procedure: MRIOther: Functional Status and Symptom Questionnaire
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2011-09-27
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 170
- Registration Number
- NCT00719147
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Molecular Analysis of Retinoblastoma
Completed
- Conditions
- Retinoblastoma
- Interventions
- Other: Tissue samples taken from retinoblastomaOther: 5 ml peripheral blood
- First Posted Date
- 2008-07-21
- Last Posted Date
- 2016-12-14
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 41
- Registration Number
- NCT00718783
- Locations
- 🇨🇱
Hospital Calvo Mackenna, Santiago, Chile
🇭🇳Hospital Escuela Bloque Materno Infantil, Tegucigalpa, Honduras
Radiofrequency Ablation of Tumors
Phase 1
Completed
- Conditions
- Primary TumorsMetastatic Tumors
- Interventions
- Procedure: Radiofrequency Tumor Ablation
- First Posted Date
- 2008-06-26
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 31
- Registration Number
- NCT00705497
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Planning Margin Requirements for Pediatric Radiation Oncology
Completed
- Conditions
- Pediatric Radiation
- First Posted Date
- 2008-06-25
- Last Posted Date
- 2011-12-01
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 375
- Registration Number
- NCT00704613
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath